Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Pathways for lower extremity superficial vein thrombosis management in an academic medical center

Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt

24-03-2025

https://doi.org/10.4081/btvb.2025.155

224

PDF: 58
Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

Gary E. Raskob

16-05-2024

https://doi.org/10.4081/btvb.2024.124

607

PDF: 335
Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

Agnes Y.Y. Lee

29-02-2024

https://doi.org/10.4081/btvb.2024.111

1518

PDF: 422
Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review

Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo

24-10-2022

https://doi.org/10.4081/btvb.2022.44

599

PDF: 189
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

04-09-2024

https://doi.org/10.4081/btvb.2024.144

955

PDF: 213

SUPPLEMENTARY MATERIAL: 99
Cancer-associated ischemic stroke: current knowledge and future directions

Ronda Lun, Deborah M. Siegal

16-05-2024

https://doi.org/10.4081/btvb.2024.117

1939

PDF: 598
The changing landscape of treatment for acquired hemophilia A

Massimo Franchini, Daniele Focosi

30-01-2025

https://doi.org/10.4081/btvb.2025.157

904

PDF: 292
Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

14-12-2022

https://doi.org/10.4081/btvb.2022.50

836

PDF: 326
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan

17-10-2022

https://doi.org/10.4081/btvb.2022.41

2266

PDF: 248

Supplementary Files: 63
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

16-05-2024

https://doi.org/10.4081/btvb.2024.118

861

PDF: 417
New perspectives for prevention of the post-thrombotic syndrome

Paolo Prandoni

22-03-2022

https://doi.org/10.4081/btvb.2022.20

1487

PDF: 457
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

Ilaria Nichele, Giuseppe Carli, Alberto Tosetto

22-04-2024

https://doi.org/10.4081/btvb.2024.104

450

PDF: 147
Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

27-07-2022

https://doi.org/10.4081/btvb.2022.34

4656

PDF: 397

Supplementary Files: 126
New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

Mehrie H. Patel, Alok A. Khorana

16-05-2024

https://doi.org/10.4081/btvb.2024.113

570

PDF: 346
Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

Ang Li, Emily Zhou

16-05-2024

https://doi.org/10.4081/btvb.2024.108

782

PDF: 399
Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

03-11-2022

https://doi.org/10.4081/btvb.2022.42

898

PDF: 292
Venous thromboembolism and mortality in patients with hematological malignancies

Kristen M. Sanfilippo, Tzu-Fei Wang

16-05-2024

https://doi.org/10.4081/btvb.2024.119

748

PDF: 340
Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia

Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga

28-06-2023

https://doi.org/10.4081/btvb.2023.72

600

PDF: 203
Stroke in women: anticoagulation in a complicated puzzle

Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona

26-08-2024

https://doi.org/10.4081/btvb.2024.137

1116

PDF: 293
Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele

08-05-2024

https://doi.org/10.4081/btvb.2024.106

969

PDF: 396
Management of atrial fibrillation: a practical and useful synopsis of last guidelines

Gualtiero Palareti

24-02-2025

https://doi.org/10.4081/btvb.2025.168

755

PDF: 6
Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

22-03-2022

https://doi.org/10.4081/btvb.2022.10

1099

PDF: 354

APPENDIX: 73
Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

16-05-2024

https://doi.org/10.4081/btvb.2024.114

547

PDF: 278
Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

Paolo Simioni, Vittorio Pengo, Paolo Prandoni

07-11-2022

https://doi.org/10.4081/btvb.2022.52

2033

PDF: 230
Welcome to the 12^th International Conference on Thrombosis and Hemostasis Issues in Cancer! Proceedings

Anna Falanga, Benjamin Brenner, Alok A. Khorana

16-05-2024

https://doi.org/10.4081/btvb.2024.138

1439

PDF: 365
Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care

Gianfranco De Girolamo, Luca Sarti, Sonia Cecoli, Karin Bonora, Chiara Ajolfi, Francesco Bellelli, Valeria Coluccio, Gualtiero Palareti, Marco Marietta

15-04-2022

https://doi.org/10.4081/btvb.2022.9

691

PDF: 221

Supplementary Files: 73
Polycythemia vera and management of the thrombotic risk: an update

Massimo Franchini

20-12-2023

https://doi.org/10.4081/btvb.2023.102

1927

PDF: 289
Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

23-05-2022

https://doi.org/10.4081/btvb.2022.28

5235

PDF: 462

APPENDIX: 123
Influence of emicizumab on protein C-mediated clotting regulation

Federica Mancazzo, Antonia Vitulli, Lavinia Dirienzo, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

25-10-2023

https://doi.org/10.4081/btvb.2023.89

1998

PDF: 246

Supplementary Material: 48
Antithrombotic therapy in idiopathic infertility

Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

03-10-2024

https://doi.org/10.4081/btvb.2024.126

1994

PDF: 487
Vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1 nCoV-19 vaccine: report of two cases

Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò

23-05-2022

https://doi.org/10.4081/btvb.2022.23

3763

PDF: 273
The role of dyslipidemia and gender-related risk factors in the management of patients with abdominal aortic aneurysms: a survey from the Italian Society of Angiology and Vascular Medicine and a call to action

Martina Berteotti, Walter Ageno, Rossella Marcucci, Andrea Stella, Paolo Zamboni, Romeo Martini

30-06-2025

https://doi.org/10.4081/btvb.2025.164

286

PDF: 93
Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker

16-05-2024

https://doi.org/10.4081/btvb.2024.120

898

PDF: 429
Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators

12-10-2023

https://doi.org/10.4081/btvb.2023.92

816

PDF: 232
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele

23-05-2022

https://doi.org/10.4081/btvb.2022.19

4676

PDF: 280
The subtle red line between combating and resolving inflammation in the cardiovascular disease, a “silent sniper”

Ciarán Kennedy, Luke J. Conroy, Braden Millar, Monica de Gaetano

30-06-2025

https://doi.org/10.4081/btvb.2025.187

303

PDF: 109
Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

Ottavia Borghese, Claudio Vincenzoni

26-06-2024

https://doi.org/10.4081/btvb.2024.141

1022

PDF: 263
The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects

Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati

22-03-2022

https://doi.org/10.4081/btvb.2022.24

1793

PDF: 259
Palestinian patients associations appeal on World Hemophilia Day

Sara Mellano

17-04-2024

https://doi.org/10.4081/btvb.2024.136

349

PDF: 106
The evolution of hemostasis genetics: from monogenic disorders to complex traits. A historical perspective

Augusto Di Castelnuovo

01-07-2025

https://doi.org/10.4081/btvb.2025.184

326

PDF: 104
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

09-03-2023

https://doi.org/10.4081/btvb.2023.53

708

PDF: 357
Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

Giovanni Tiscia, Elvira Grandone

13-09-2022

https://doi.org/10.4081/btvb.2022.43

2201

PDF: 259
Interaction between adenosine diphosphate receptors and protein-kinase C isoforms in platelet adhesion under flow condition

Boris Shenkman, Ivan Budnik, Yulia Einav

16-02-2023

https://doi.org/10.4081/btvb.2023.51

1285

pdf: 229
Ankle brachial index for the diagnosis of asymptomatic lower extremity peripheral arterial disease

Francesco Cicconi

05-07-2024

https://doi.org/10.4081/btvb.2024.128

1350

PDF: 379

1 - 44 of 44 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy